This inventor holds 1 USPTO granted patent and 15 published patent applications. Top assignee: Auxilium US Holdings, LLC. Active years: 2010.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2010
Title: The Innovations of Benjamin J Del Tito, Jr.
Introduction
Benjamin J Del Tito, Jr. is an accomplished inventor based in Doylestown, PA (US). He has made significant contributions to the field of medicine, particularly in the treatment of collagen-mediated diseases. His innovative work has led to the development of a unique drug product that showcases his expertise and dedication to improving healthcare.
Latest Patents
Del Tito holds a patent for "Compositions and methods for treating collagen-mediated diseases." This patent describes a drug product that comprises a combination of highly purified collagenase I and collagenase II. The drug product includes these enzymes in a ratio of about 1 to 1, with a purity of greater than at least 95%. Additionally, the invention discloses improved fermentation and purification processes for preparing the drug product. He has 1 patent to his name.
Career Highlights
Del Tito is currently associated with Auxilium US Holdings, LLC, where he continues to work on innovative solutions in the pharmaceutical industry. His career has been marked by a commitment to research and development, focusing on enhancing treatment options for patients suffering from collagen-related conditions.
Collaborations
Throughout his career, Del Tito has collaborated with notable colleagues, including Gregory L Sabatino and Phillip J Bassett. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas.
Conclusion
Benjamin J Del Tito, Jr. exemplifies the spirit of innovation in the medical field. His contributions through his patent and work at Auxilium US Holdings, LLC highlight his commitment to advancing healthcare solutions. His ongoing efforts continue to inspire future advancements in the treatment of collagen-mediated diseases.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile